Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck

N Pyatigorskaya1,2, R De Laroche3, G Bera4

  • 1From Assistance Publique Hôpitaux de Paris Neuroradiology Department (N.P., E.C., D.D., M.A.-S.) nadya.pyatigorskaya@gmail.com.

Abstract

Insights

Gadolinium contrast does not improve head and neck cancer delineation on 18F-FDG-PET/MR imaging. This finding suggests contrast agents may be safely omitted in this workflow, streamlining imaging procedures.

Area of Science:

  • Oncology
  • Radiology
  • Nuclear Medicine

Background:

  • Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) combines metabolic and soft-tissue contrast information for head and neck cancer.
  • 18F-FDG PET/MRI is a valuable tool for staging and restaging head and neck cancers.

Purpose of the Study:

  • To assess the added value of gadolinium contrast-enhanced sequences for tumor delineation in head and neck cancers using 18F-FDG PET/MRI.
  • To determine if contrast agents improve the accuracy of tumor staging and restaging in head and neck cancer patients.

Main Methods:

  • Retrospective analysis of 30 patients undergoing simultaneous 18F-FDG PET/MRI for head and neck cancer.
  • Two reading sessions were conducted: one without contrast-enhanced MRI sequences and one with T1WI postcontrast sequences.
  • Tumor invasion and lymph node extension were assessed in 45 anatomic regions and compared to histopathology, with Cohen's kappa and diagnostic accuracy calculated.

Main Results:

  • Excellent agreement (Cohen κ = 0.96) was observed between contrast-free and postgadolinium reading sessions for tumor delineation.
  • Diagnostic accuracy was high and similar for both reading sessions (0.97).
  • Sensitivity and specificity for detecting tumor invasion and lymph node extension were good to excellent in both contrast-free and postgadolinium settings.

Conclusions:

  • Gadolinium contrast administration does not provide added value for the accurate characterization of primary head and neck tumor extension.
  • Contrast-enhanced sequences can potentially be omitted from the 18F-FDG PET/MRI imaging workflow for head and neck cancers.
  • This omission may streamline the imaging process without compromising diagnostic accuracy.

Related Concept Videos